MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Aug. 03, 2022 (GLOBE NEWSWIRE) — ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its second quarter 2022 financial results on Tuesday, August 9, 2022, at 8:30 AM Eastern time.
Larry Jasinski, Chief Executive Officer, and Almog Adar, Director of Finance, will host a conference call to discuss the results as follows:
| Time | 8:30 A.M EDT |
| Toll free (U.S.) | (866) 374-5140 |
| International (U.S) | (404) 400-0571 |
| Germany | 8001897777 |
| Israel | 4044000571 |
| Access Code | 43100176# |
| Webcast (live and replay) | https://edge.media-server.com/mmc/p/fz7je7rr under the ‘Investors’ section’. |
The archived webcast will be available via the following link
https://edge.media-server.com/mmc/p/fz7je7rr or through the ‘Investors’ section’ on www.rewalk.com.
About ReWalk Robotics Ltd.
ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke. ReWalk’s mission is to fundamentally change the quality of life for individuals with lower limb disability through the creation and development of market leading robotic technologies. Founded in 2001, ReWalk has headquarters in the U.S., Israel and Germany. For more information on the ReWalk systems, please visit www.rewalk.com.
ReWalk® is a registered trademark of ReWalk Robotics Ltd. in Israel and the Unites States.
Investor Contact:
Almog Adar
Director of Finance
ReWalk Robotics Ltd.
T: +972-4-9590130
E: investorrelations@rewalk.com
TAMPA, Fla., March 27, 2024 /PRNewswire/ -- Greenway Health, a leading health information technology services provider, announced its strategic…
List Based on an Independent Survey of 25,000 U.S. ResidentsREMOTE-FIRST COMPANY/NEW YORK--(BUSINESS WIRE)--#NextGenHealthcare--NextGen Healthcare, a…
Fuller will help drive the growth and innovation of strategic communications firmCARLSBAD, Calif.--(BUSINESS WIRE)--#AppointmentNews--Ford Hutman…
Microsoft Azure customers worldwide can now purchase Lightbeam’s care orchestration technology suite directly from the…
General Catalyst leads funding round joined by .406 Ventures, Valtruis, Mass General Brigham Ventures, and…
PHOENIX--(BUSINESS WIRE)--Creative Medical Technology Holdings, Inc., (“Creative Medical Technology” or the “Company”) (NASDAQ: CELZ), a…